SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...

Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, to launch and ...

Sophia Genetics (SOPH) announced a collaboration with Complete Genomics, a company dealing in genomic sequencing, to launch and co-market MSK-ACCESS and MSK-IMPACT powered with SOPHiA DDM on Complete ...

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an ...

Questel, a world leader in intellectual property (IP) solutions, today launched its new AI-assisted Sophia Platform which includes Sophia Search, Document, Query and Lab solutions. Industry-leading ...

A clinically validated screening tool, now redesigned for parents with AI support and instant results at home. ATLANTA, Aug. 25, 2025 /PRNewswire/ -- Neo Sophia today announced the launch of Screener, ...

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2025 before U.S. markets open on Tuesday, ...